These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20112299)

  • 1. The effect of co-administered flavonoids on the metabolism of hesperetin and the disposition of its metabolites in Caco-2 cell monolayers.
    Brand W; Padilla B; van Bladeren PJ; Williamson G; Rietjens IM
    Mol Nutr Food Res; 2010 Jun; 54(6):851-60. PubMed ID: 20112299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers.
    Brand W; van der Wel PA; Rein MJ; Barron D; Williamson G; van Bladeren PJ; Rietjens IM
    Drug Metab Dispos; 2008 Sep; 36(9):1794-802. PubMed ID: 18515333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of hesperetin glucuronide conjugates with human BCRP, MRP2 and MRP3 as detected in membrane vesicles of overexpressing baculovirus-infected Sf9 cells.
    Brand W; Oosterhuis B; Krajcsi P; Barron D; Dionisi F; van Bladeren PJ; Rietjens IM; Williamson G
    Biopharm Drug Dispos; 2011 Dec; 32(9):530-5. PubMed ID: 22083890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers.
    Schutte ME; Freidig AP; van de Sandt JJ; Alink GM; Rietjens IM; Groten JP
    Toxicol Appl Pharmacol; 2006 Dec; 217(2):204-15. PubMed ID: 16997339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transepithelial transport of hesperetin and hesperidin in intestinal Caco-2 cell monolayers.
    Kobayashi S; Tanabe S; Sugiyama M; Konishi Y
    Biochim Biophys Acta; 2008 Jan; 1778(1):33-41. PubMed ID: 18021752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of efflux transporters involved in distribution and disposition of apixaban.
    Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
    Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective conjugation, transport and bioactivity of s- and R-hesperetin enantiomers in vitro.
    Brand W; Shao J; Hoek-van den Hil EF; van Elk KN; Spenkelink B; de Haan LH; Rein MJ; Dionisi F; Williamson G; van Bladeren PJ; Rietjens IM
    J Agric Food Chem; 2010 May; 58(10):6119-25. PubMed ID: 20441166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic exposure to short-chain fatty acids modulates transport and metabolism of microbiome-derived phenolics in human intestinal cells.
    Van Rymenant E; Abrankó L; Tumova S; Grootaert C; Van Camp J; Williamson G; Kerimi A
    J Nutr Biochem; 2017 Jan; 39():156-168. PubMed ID: 27840292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycyclic aromatic hydrocarbons in food--efflux of the conjugated biomarker 1-hydroxypyrene is mediated by Breast Cancer Resistance Protein (ABCG2) in human intestinal Caco-2 cells.
    Hessel S; Lampen A; Seidel A
    Food Chem Toxicol; 2013 Dec; 62():797-804. PubMed ID: 24140465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein.
    Yang Z; Zhu W; Gao S; Yin T; Jiang W; Hu M
    Drug Metab Dispos; 2012 Oct; 40(10):1883-93. PubMed ID: 22736306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.
    Brand W; Schutte ME; Williamson G; van Zanden JJ; Cnubben NH; Groten JP; van Bladeren PJ; Rietjens IM
    Biomed Pharmacother; 2006 Nov; 60(9):508-19. PubMed ID: 16978825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hop-derived prenylflavonoids are substrates and inhibitors of the efflux transporter breast cancer resistance protein (BCRP/ABCG2).
    Tan KW; Cooney J; Jensen D; Li Y; Paxton JW; Birch NP; Scheepens A
    Mol Nutr Food Res; 2014 Nov; 58(11):2099-110. PubMed ID: 25044854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of a basolateral transporter in rosuvastatin transport and its interplay with apical breast cancer resistance protein in polarized cell monolayer systems.
    Li J; Wang Y; Zhang W; Huang Y; Hein K; Hidalgo IJ
    Drug Metab Dispos; 2012 Nov; 40(11):2102-8. PubMed ID: 22855735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra.
    Cao J; Chen X; Liang J; Yu XQ; Xu AL; Chan E; Wei D; Huang M; Wen JY; Yu XY; Li XT; Sheu FS; Zhou SF
    Drug Metab Dispos; 2007 Apr; 35(4):539-53. PubMed ID: 17220245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux.
    An G; Gallegos J; Morris ME
    Drug Metab Dispos; 2011 Mar; 39(3):426-32. PubMed ID: 21139040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship.
    Katayama K; Masuyama K; Yoshioka S; Hasegawa H; Mitsuhashi J; Sugimoto Y
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):789-97. PubMed ID: 17345086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
    Dahan A; Amidon GL
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
    Lin X; Skolnik S; Chen X; Wang J
    Drug Metab Dispos; 2011 Feb; 39(2):265-74. PubMed ID: 21051535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Critical Evaluation of In Vitro Hesperidin 2S Bioavailability in a Model Combining Luminal (Microbial) Digestion and Caco-2 Cell Absorption in Comparison to a Randomized Controlled Human Trial.
    Van Rymenant E; Salden B; Voorspoels S; Jacobs G; Noten B; Pitart J; Possemiers S; Smagghe G; Grootaert C; Van Camp J
    Mol Nutr Food Res; 2018 Apr; 62(8):e1700881. PubMed ID: 29451355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of axitinib interactions with human efflux and hepatic uptake transporters: implications for disposition and drug interactions.
    Reyner EL; Sevidal S; West MA; Clouser-Roche A; Freiwald S; Fenner K; Ullah M; Lee CA; Smith BJ
    Drug Metab Dispos; 2013 Aug; 41(8):1575-83. PubMed ID: 23729661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.